Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease
- PMID: 6628510
- DOI: 10.1007/BF00543800
Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease
Abstract
Plasma aspirin, salicylate and salicyluric acid concentrations were monitored in young, elderly and alcoholic subjects after ingestion of a single 1.2 g dose of soluble aspirin. The plasma aspirin, salicylate and unbound salicylate concentration-time profiles varied considerably between individual subjects. Most of the pharmacokinetic parameters derived from these profiles were not significantly different between young subjects, elderly subjects and subjects with alcoholic liver disease. Individual plasma albumin concentrations provided a better index of the unbound plasma salicylate clearances and salicylate plasma protein binding than the age of the subject or the presence of alcoholic liver disease. Highest unbound plasma salicylate concentrations were found in subjects with the lowest plasma albumin concentrations.
Similar articles
-
Clinical pharmacokinetics of the salicylates.Clin Pharmacokinet. 1985 Mar-Apr;10(2):164-77. doi: 10.2165/00003088-198510020-00004. Clin Pharmacokinet. 1985. PMID: 3888490 Review.
-
Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin.Arthritis Rheum. 1986 Aug;29(8):971-80. doi: 10.1002/art.1780290805. Arthritis Rheum. 1986. PMID: 3741521
-
Clinical pharmacokinetics of salicylates: a re-assessment.Br J Clin Pharmacol. 1980 Oct;10 Suppl 2(Suppl 2):285S-290S. doi: 10.1111/j.1365-2125.1980.tb01811.x. Br J Clin Pharmacol. 1980. PMID: 7437270 Free PMC article.
-
Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.Clin Pharmacol Ther. 1986 Nov;40(5):518-24. doi: 10.1038/clpt.1986.217. Clin Pharmacol Ther. 1986. PMID: 3769383
-
Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction.Circulation. 1985 Dec;72(6):1185-93. doi: 10.1161/01.cir.72.6.1185. Circulation. 1985. PMID: 2998640 Review.
Cited by
-
Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose.J Pharmacokinet Biopharm. 1991 Oct;19(5):575-95. doi: 10.1007/BF01062964. J Pharmacokinet Biopharm. 1991. PMID: 1783992
-
Nonsteroidal anti-inflammatory drugs. Differential use in older patients.Drugs Aging. 1994 Feb;4(2):101-12. doi: 10.2165/00002512-199404020-00003. Drugs Aging. 1994. PMID: 8186538 Review.
-
Salicylate pharmacokinetics in patients with rheumatoid arthritis.Br J Clin Pharmacol. 1989 Oct;28(4):449-61. doi: 10.1111/j.1365-2125.1989.tb03526.x. Br J Clin Pharmacol. 1989. PMID: 2590603 Free PMC article.
-
The problems and pitfalls of NSAID therapy in the elderly (Part II).Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005. Drugs Aging. 1991. PMID: 1794015 Review.
-
Plasma protein binding of drugs in the elderly.Clin Pharmacokinet. 1987 Jan;12(1):41-72. doi: 10.2165/00003088-198712010-00004. Clin Pharmacokinet. 1987. PMID: 3545616 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical